1699-695X

S1699-695X2020000300180

España

00 00 2020

13 3 180 189

2012 65 3 3

241-8

2010 55 21 21

2390-8

2004 93 2 2

159-64

2002 288 21 21

2709-16

2004 43 5 5

963-9

2004 20 9 9

1365-70

2004 22 ^s2 ^s2 2

Prospective Studies Collaboration 2002 360 9349 9349

1903-13

2011 123 16 16

1737-44

2013 31 7 7

1281-357

2007 25 6 6

1105-87

EUROASPIRE Study Group

2009 373 9667 9667

929-40

EUROASPIRE Study Group

2009 16 2 2

121-37

2012 30 1 1

168-76

2016 37 29 29

2315-81

2015 8 3 3

207-15

2006 4 2 2

101-3

1998 97 18 18

1837-47

2003 56 3 3

221-9

2003 120 5 5

172-4

National Heart, Lung and Blood Institute American Heart Association

2004 109 3 3

433-8

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

2001 285 19 19

2486-97

International Diabetes Federation 2005

Comité Internacional de Clasificación de la WONCA 1999 2

Ministerio de Sanidad, Servicios Sociales e Igualdad 2014 9

2019 12 81 81

4800-3

1991 14 3 3

173-94

2005 165 22 22

2644-50

2005 124 10 10

368-70

2007 207 2 2

64-8

2018 30 5 5

197-208

2010 2 10 10

180-93

2006 126 11 11

406-9

2004 123 16 16

601-5

2012 138 4 4

145-50

2008 61 11 11

1150-8

2008 8

2009 109 2 2

236-44

2003 108 13 13

1546-51

2011 64 11 11

988-96

2016 23 6 6

636-48

2016 69 6 6

572-8

2010 53 4 4

600-5

2020 11

2007 49 4 4

403-14

2008 371 9628 9628

1927-35

2010 211 2 2

612-7

2010 56 14 14

1113-32